An injectable hydrogel as bone graft material with added antimicrobial properties

Giacomo, Tommasi, Perni, Stefano and Prokopovich, Polina ORCID: https://orcid.org/0000-0002-5700-9570 2016. An injectable hydrogel as bone graft material with added antimicrobial properties. Tissue Engineering: Parts A, B, and C 22 (11-12) , pp. 862-872. 10.1089/ten.tea.2016.0014

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (622kB) | Preview

Abstract

Currently, the technique which provides the best chances for a successful bone graft, is the use of bone tissue from the same patient receiving it (autograft); the main limitations are the limited availability and the risks involved in removing living bone tissue, for example, explant site pain and morbidity. Allografts and xenografts may overcome these limitations; however, they increase the risk of rejection. For all these reasons the development of an artificial bone graft material is particularly important and hydrogels are a promising alternative for bone regeneration. Gels were prepared using 1,4-butanediol diacrylate as crosslinker and alpha tricalciumphosphate; ZnCl2 and SrCl2 were added to the aqueous phase. MTT results demonstrated that the addition of strontium had a beneficial effect on the osteoblast cells density on hydrogels, and zinc instead did not increase osteoblast proliferation. The amount of calcium produced by the osteoblast cells quantified through the Alizarin Red protocol revealed that both strontium and zinc positively influenced the formation of calcium; furthermore, their effect was synergistic. Rheology properties were used to mechanically characterize the hydrogels and especially the influence of crosslinker's concentration on them, showing the hydrogels presented had extremely good mechanical properties. Furthermore, the antimicrobial activity of strontium and zinc in the hydrogels against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis was determined

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Publisher:	Mary Ann Liebert
ISSN:	1937-3368
Date of First Compliant Deposit:	17 May 2016
Date of Acceptance:	12 May 2016
Last Modified:	05 May 2023 23:39
URI:	https://orca.cardiff.ac.uk/id/eprint/90936

Citation Data

Cited 21 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item